D1 Capital Partners L.P. 13D and 13G filings for Lexeo Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-05-15 09:58 am Sale |
2025-03-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
D1 Capital Partners L.P. | 978,652 2.900% |
-1,527,955 (-60.96%) |
Filing |
| 2024-02-14 06:04 am Purchase |
2023-12-31 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO |
D1 Capital Partners L.P. | 2,506,607 9.400% |
2,506,607 (New Position) |
Filing |